These findings indicate a potential mechanism whereby the upregulation of LDHA contributes to metabolic disorders and proinflammatory responses, consequently affecting the prognostic outcomes of individuals with NAFLD that progresses to HCC. The gene discussed is LDHA; the disease is metabolic disease.